Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
Interleukin-34 (IL-34) was initially identified as an alternative ligand for the colony-stimulating factor-1 receptor (CSF-1R) to mediate the biology of mononuclear phagocytic cells. Recently, IL-34 was found to be associated with chronic inflammation, such as in rheumatoid arthritis (RA). Both RA a...
Main Authors: | Hongxu Wang, Ju Cao, Xiaofei Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/22/1/35 |
Similar Items
-
IL-10 mediates pleural remodeling in systemic lupus erythematosus
by: Qian Niu, et al.
Published: (2024-11-01) -
T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
by: Anselm Mak
Published: (2022-03-01) -
A case of childhood systemic lupus erythematosus
by: Hong Wan, et al.
Published: (2025-01-01) -
Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01) -
Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
by: Zahra Rezaieyazdi, et al.
Published: (2022-01-01)